Qu Biologics Inc.
4475 Wayburne Drive - Suite 305 V5G 4X4 Burnaby, BC, Canada

Qu Biologics Inc. CEO Dr Hal Gunn and founder Rob Freeman were recently interviewed by Dalhia Kurtz, host of The Goods, on 580 CFRA, about Qu's hopeful solution to #covid19 and future #pandemics. Listen to the radio interview here, http://ow.ly/hMUf50AxcSi.

Qu Biologics Inc. CEO Dr. Hal Gunn was recently interviewed on CBC Politics chating about Qu's hopeful response to #covid19! Hosted by Vassy Kapelos, you can watch the interview here, http://ow.ly/pBLR50A9Alf. The interview starts 1:13:20 and finishes 1:20:08. #cbc #pandemic #medicine #therapy

Qu Biologics Inc. is ready, willing, and able to join the fight against the current #covid19 #pandemic (and future ones!) using our unique SSI therapeutic platform. Read our LifeSciences British Columbia announcement, http://ow.ly/aDIo50zGFXt. You can also learn more from our brief overview describing how Qu's SSIs can be applied to viral infections, http://ow.ly/eYYS50zGI7n.

The therapeutic applications could be a #gamechanger! Qu Biologics Inc. publishes landmark science paper showing how the innate immune system can be recruited and activated to a specific site in the human body to treat disease. Read our peer reviewed publication, http://ow.ly/OIw450z6QmD. What does this mean? Qu's SSIs could help "train" your innate immune system to treat diseases like #covid19 #cancer #ibd #crohnsdisease #asthma #ulcerativecolitis #infections.... Learn more from our press release, http://ow.ly/Kand50z6QjM. #medicine #biotech #pharma

Qu Biologics Inc. wishes to thank all of our supporters!! We completed enrolling 20 patients in our 1st stage of our Phase 2 clinical trial for #crohnsdisease. The current trial is expected to finish by late 2020. Visit http://ow.ly/f3gT50xEw1G to read the official press release. What does this mean for our future trials in #IBD including #crohns and #ulcerativecolitis? The reality is that operating clinical trials is very resource intensive, especially funding. No timelines ...have been set. The 2nd stage of our Phase 2 clinical trial for Crohn's disease is anticipated to be a multi-centre and multi-national trial. Interested in joining our Crohn's disease trial wait list? Sign-up here, https://www.quibd.com/phase-2-clinical-trial-trial/. Seasons greeting, happy new year, and we hope that everyone has an amazing 2020.

Our friends at GenomeBC are hosting a seminar presented by Dr. Claire M. Fraser about the human microbiome and the role it plays in health and disease. Date and Time: Thu, 24 October 2019 4:30 PM 7:00 PM PDT... Location: Vancouver Convention Centre West Building 1055 Canada Place Rooms 220-222 Vancouver, BC Visit, http://ow.ly/MC3t50wSk6P, for more info. #DRDK2019

With regret, Jim's presentation hosted by Crohn's and Colitis Canada - Vancouver has been cancelled for this Thursday, Oct-24. If a future opportunity to reengage becomes available, notifications will follow.

Join us for a Crohn's and Colitis Canada - Vancouver sponsored information session. Jim Pankovich from Qu Biologics Inc. has been invited to talk about "Issues to Consider When Exploring New Treatment Options or Clinical Trials" on Oct-24-2019, 630pm at the Renfrew Library Main Meeting Room, 2969 E 22nd Ave, Vancouver, BC. Want to attend? Please register with Teri, [email protected] or 1-250-213-7761.

Curious what our recent poster presentation at the #CICON19 conference was all about? Download our poster, http://ow.ly/Ymjj50wyzmZ, about how Qu Biologics Inc.'s SSI platform can significantly enhance adoptive cell therapy for solid #cancer. Reach out if you have any questions.

Qu Biologics Inc. Director of Scientific Innovation, Dr. Kalyan, will be presenting data that our immunotherapy platform can significantly enhance adoptive cell therapy for solid #cancer at #CICON2019 - Session A (abstract number A055). Learn more about the conference here, www.cancerimmunotherapyconference.org.

Tired of the pain and discomfort caused by #crohns disease? Join our RESTORE research study evaluating an investigational new treatment and help advance medical research for the Crohn's community. Visit www.quibd.com to learn more.

Did you know there are 5 types of #Crohns disease affecting different areas of the GI tract? It has become a top health priority in Canada to find a cure. Help our research by joining the RESTORE clinical study to evaluate an investigational new treatment. Visit www.quibd.com to learn more.